Showing results (1-10 of 858) with videos related to
Sort By:
Pageof 86
Journal of the Neurological Sciences|March 21, 2007
Multiple sclerosis: disease biomarkers as indicated by pathophysiologyThomas Berger, Markus ReindlDisease Markers|November 25, 2006
Biomarkers in multiple sclerosis: role of antibodiesThomas Berger, Markus ReindlJournal of Neuroimmunology|August 29, 2006
Antibodies as biological markers for pathophysiological processes in MSMarkus Reindl, Michael Khalil, Thomas BergerCentral Nervous System Agents in Medicinal Chemistry|March 19, 2010
Multiple sclerosis - established and novel therapeutic approachesRainer Ehling, Thomas Berger, Markus ReindlCurrent Medicinal Chemistry|August 21, 2007
Biological markers for multiple sclerosisAndreas Lutterotti, Thomas Berger, Markus ReindlResults and Problems in Cell Differentiation|June 11, 2009
B cells and antibodies in MSMarkus Reindl, Bettina Kuenz, Thomas BergerMultiple Sclerosis and Related Disorders|March 11, 2018
New clinical implications of anti-myelin oligodendrocyte glycoprotein antibodies in children with CNS demyelinating diseasesFranziska Di Pauli, Markus Reindl, Thomas BergerNature Reviews. Neurology|August 15, 2022
Pathogenic autoantibodies in multiple sclerosis - from a simple idea to a complex conceptRomana Höftberger, Hans Lassmann, Thomas Berger, et al.Current Opinion in Neurology|March 2, 2017
Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they?Markus Reindl, Sven Jarius, Kevin Rostasy, et al.Expert Opinion on Medical Diagnostics|March 16, 2013
Diagnostic biomarkers in multiple sclerosisBettina Kuenz, Florian Deisenhammer, Thomas Berger, et al.Pageof 86